Meng Xiangjiao相关文献与解析，生知库 | 链接生命科学的每一步

Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia

7天雾化吸入表没食子儿茶素-3-没食子酸酯治疗合并COVID-19肺炎的肿瘤患者的疗效和安全性

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-026-15553-x

Zhu, Wanqi; Jia, Li; Qiao, Qiang; Li, Xiaolin; Peng, Xie; Meng, Xiangjiao; Kong, Lingling; Zhao, Hanxi

Sodium glycididazole combined with definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: A multicenter randomized clinical trial

缩水甘油唑钠联合根治性放化疗治疗食管鳞状细胞癌：一项多中心随机临床试验

期刊:Precision Radiation Oncology

影响因子:2.1

doi:10.1002/pro6.70052

Li, Xiaoling; Zhao, Hanxi; Xie, Peng; Zhu, Wanqi; Liu, Liping; Wu, Peipei; Sheng, Yanxing; Wang, Chuandong; Song, Yipeng; Meng, Xiangjiao; Zhang, Jiandong; Xing, Ligang

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial

HA121-28 在晚期实体瘤和 RET 融合阳性非小细胞肺癌患者中的安全性、药代动力学和疗效：一项多中心、开放标签、单臂 1/2 期试验

期刊:Signal Transduction and Targeted Therapy

影响因子:52.7

doi:10.1038/s41392-025-02155-5

Ruan, Dan-Yun; Huang, Wen-Wen; Li, Yongsheng; Zhao, Yanqiu; Shi, Yehui; Jia, Yuming; Cang, Shundong; Zhang, Wei; Shi, Jianhua; Chen, Jun; Lin, Jie; Liu, Yunpeng; Xu, Jianming; Ouyang, Weiwei; Fang, Jian; Zhuang, Wu; Liu, Caigang; Bu, Qing; Li, Manxiang; Meng, Xiangjiao; Sun, Meili; Yang, Nong; Dong, Xiaorong; Pan, Yueyin; Li, Xingya; Qu, Xiujuan; Zhang, Tongmei; Yuan, Xianglin; Hu, Sheng; Guo, Wei; Li, Yalun; Li, Shengqing; Liu, Dongying; Song, Feixue; Tan, Liping; Yu, Yan; Yu, Xinmin; Zang, Aimin; Sun, Chang; Zhang, Qian; Zou, Kai; Dan, Mo; Xu, Rui-Hua; Zhao, Hongyun

Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS(G12C) inhibitor-naïve Chinese patients with KRAS(G12C)-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies

IBI351（富泽拉西布）单药治疗KRAS(G12C)突变型转移性结直肠癌且既往未接受过KRAS(G12C)抑制剂治疗的中国患者的疗效和安全性：两项研究I期部分的汇总分析

期刊:Signal Transduction and Targeted Therapy

影响因子:52.7

doi:10.1038/s41392-025-02315-7

Yuan, Ying; Deng, Yanhong; Jin, Yongdong; Guo, Zengqing; Pan, Yueyin; Wang, Cunji; Wang, Zhiwu; Hu, Yi; Hua, Dong; Meng, Xiangjiao; Zhang, Zhiye; Zhao, Mingfang; Dong, Xiaorong; Huang, Dingzhi; Li, Xiaoyan; Liu, Lian; Sun, Meili; Wang, Huijuan; Wang, Xiuwen; Yang, Nong; Zhang, Mingjun; Hu, Sheng; Wu, Dongde; Huang, Jingjing; Zhang, Sujie; Huang, Mengna; Ding, Kefeng

A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.

针对晚期实体瘤的 B7H3 靶向抗体药物偶联物：一项 1/1b 期试验

期刊:Nature Medicine

影响因子:50

doi:10.1038/s41591-025-03600-2

Ma Yuxiang, Yang Yunpeng, Huang Yan, Fang Wenfeng, Xue Jinhui, Meng Xiangjiao, Fan Yun, Fu Siqing, Wu Lin, Zheng Yulong, Liu Jian, Liu Zhihua, Zhuang Wu, Rosen Seth, Qu Song, Li Bihui, Li Mingjun, Zhao Yanqiu, Yang Shujun, Ji Yinghua, Sommerhalder David, Luo Suxia, Yang Kunyu, Li Jingao, Lv Dongqing, Zhang Peng, Zhao Yuanyuan, Hong Shaodong, Zhang Yang, Zhao Shen, Chin Steve, Zhang Xian, Lian Wei, Cai Jiaqiang, Xue Tongtong, Zhang Li, Zhao Hongyun

免疫/内分泌

发表日期：2025

文献求助收藏

Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial

Sacituzumab tirumotecan 与多西他赛治疗既往接受过治疗的 EGFR 突变晚期非小细胞肺癌：一项多中心、开放标签、随机对照试验

期刊:Bmj-British Medical Journal

影响因子:42.7

doi:10.1136/bmj-2025-085680

Fang, Wenfeng; Li, Xingya; Wang, Qiming; Meng, Xiangjiao; Zheng, Wei; Sun, Longhua; Yao, Wenxiu; Zhuang, Wu; Fan, Yun; Zhuo, Minglei; Luo, Yongzhong; Zhang, Zhiye; Song, Xia; Yang, Runxiang; Yang, Jiacheng; Jin, Xiaoping; Diao, Yina; Ge, Junyou; Zhang, Li

Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer

双特异性抗体在非小细胞肺癌治疗中的应用及未来前景

期刊:Cancer Biology & Medicine

影响因子:8.4

doi:10.20892/j.issn.2095-3941.2024.0470

Wen, Junxu; Cui, Wenxing; Yin, Xiaoyan; Chen, Yu; Liu, Ailing; Wang, Qian; Meng, Xiangjiao

COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1(+)CD8(+) T cell infiltration in NSCLC

COX-2抑制剂通过促进TCF1(+)CD8(+) T细胞浸润非小细胞肺癌，与放射免疫疗法产生协同作用。

期刊:Cancer Biology & Medicine

影响因子:8.4

doi:10.20892/j.issn.2095-3941.2025.0205

Ma, Lin; Bai, Menglin; Wang, Yao; Zhai, Xueying; Yu, Jinming; Meng, Xiangjiao

CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study

基于CT的放射组学-深度学习模型预测早期肺腺癌患者的隐匿性淋巴结转移：一项多中心研究

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.21147/j.issn.1000-9604.2025.01.02

Yin, Xiaoyan; Lu, Yao; Cui, Yongbin; Zhou, Zichun; Wen, Junxu; Huang, Zhaoqin; Yan, Yuanyuan; Yu, Jinming; Meng, Xiangjiao

The landscape of bispecific T cell engager in cancer treatment

双特异性T细胞衔接器在癌症治疗中的应用现状

Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia

7天雾化吸入表没食子儿茶素-3-没食子酸酯治疗合并COVID-19肺炎的肿瘤患者的疗效和安全性

Sodium glycididazole combined with definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: A multicenter randomized clinical trial

缩水甘油唑钠联合根治性放化疗治疗食管鳞状细胞癌：一项多中心随机临床试验

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial

HA121-28 在晚期实体瘤和 RET 融合阳性非小细胞肺癌患者中的安全性、药代动力学和疗效：一项多中心、开放标签、单臂 1/2 期试验

Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS(G12C) inhibitor-naïve Chinese patients with KRAS(G12C)-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies

IBI351（富泽拉西布）单药治疗KRAS(G12C)突变型转移性结直肠癌且既往未接受过KRAS(G12C)抑制剂治疗的中国患者的疗效和安全性：两项研究I期部分的汇总分析

A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.

针对晚期实体瘤的 B7H3 靶向抗体药物偶联物：一项 1/1b 期试验

Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial

Sacituzumab tirumotecan 与多西他赛治疗既往接受过治疗的 EGFR 突变晚期非小细胞肺癌：一项多中心、开放标签、随机对照试验

Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer

双特异性抗体在非小细胞肺癌治疗中的应用及未来前景

COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1(+)CD8(+) T cell infiltration in NSCLC

COX-2抑制剂通过促进TCF1(+)CD8(+) T细胞浸润非小细胞肺癌，与放射免疫疗法产生协同作用。

CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study

基于CT的放射组学-深度学习模型预测早期肺腺癌患者的隐匿性淋巴结转移：一项多中心研究